Moreover, this study highlights the relevance of considering not only COPD phenotypes but also COPD endotypes (expression levels of Ppargc1a and/or Dio2) in the research and development of better treatment approaches for COPD. The gene discussed is PPARGC1A; the disease is chronic obstructive pulmonary disease.